These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1116 related articles for article (PubMed ID: 25583891)

  • 1. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.
    van Dijk W; Tan W; Li P; Guo B; Li S; Benedetti A; Bourbeau J;
    Ann Fam Med; 2015; 13(1):41-8. PubMed ID: 25583891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misidentification of airflow obstruction: prevalence and clinical significance in an epidemiological study.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():535-40. PubMed ID: 25792821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population.
    Chung KS; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Song JH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1957-63. PubMed ID: 27578970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COPD in chronic heart failure: less common than previously thought?
    Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF
    Heart Lung; 2013; 42(5):365-71. PubMed ID: 23998385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS).
    Torén K; Olin AC; Lindberg A; Vikgren J; Schiöler L; Brandberg J; Johnsson Å; Engström G; Persson HL; Sköld M; Hedner J; Lindberg E; Malinovschi A; Piitulainen E; Wollmer P; Rosengren A; Janson C; Blomberg A; Bergström G
    Int J Chron Obstruct Pulmon Dis; 2016; 11():927-33. PubMed ID: 27194908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Utility of normality low limit of spirometry in diagnosed COPD patients].
    Naveiro-Rilo JC; García García S; Flores-Zurutuza L; Carazo Fernández L; Domínguez Fernández C; Palomo García JL
    Rev Calid Asist; 2017; 32(5):262-268. PubMed ID: 28863965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overweight and obesity may lead to under-diagnosis of airflow limitation: findings from the Copenhagen City Heart Study.
    Çolak Y; Marott JL; Vestbo J; Lange P
    COPD; 2015 Feb; 12(1):5-13. PubMed ID: 25290888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed ratio or lower limit of normal for the FEV
    Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U
    Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airflow limitation classified with the fixed ratio or the lower limit of normal and cause-specific mortality - A prospective study.
    Torén K; Andersson M; Olin AC; Blanc PD; Järvholm B
    Respir Med; 2018 Nov; 144():36-41. PubMed ID: 30366582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of the lower limit of normal of FEV
    Liu S; Zhou Y; Liu S; Zou W; Li X; Li C; Deng Z; Zheng J; Li B; Ran P
    Respir Med; 2018 Jun; 139():27-33. PubMed ID: 29857998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicted lower limit of normal reduces misclassification risk of airflow limitation in asymptomatic elderly never-smokers.
    Wang Y; Xiao W; Ma DD; Jiang YY
    Chin Med J (Engl); 2013; 126(18):3486-92. PubMed ID: 24034095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review.
    Mohamed Hoesein FA; Zanen P; Lammers JW
    Respir Med; 2011 Jun; 105(6):907-15. PubMed ID: 21295958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupational exposure to vapor, gas, dust, or fumes and chronic airflow limitation, COPD, and emphysema: the Swedish CArdioPulmonary BioImage Study (SCAPIS pilot).
    Torén K; Vikgren J; Olin AC; Rosengren A; Bergström G; Brandberg J
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3407-3413. PubMed ID: 29238185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of diagnostic criteria on the prevalence of COPD.
    Çolak Y; Løkke A; Marott JL; Lange P; Vestbo J
    Clin Respir J; 2013 Jul; 7(3):297-303. PubMed ID: 23072716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of respiratory symptoms in persons with restrictive ventilatory impairment compared with persons with chronic obstructive pulmonary disease: The PLATINO study.
    Nonato NL; Nascimento OA; Padilla RP; de Oca MM; Tálamo C; Valdivia G; Lisboa C; López MV; Celli B; Menezes AM; Jardim JR
    Chron Respir Dis; 2015 Aug; 12(3):264-73. PubMed ID: 26041119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airflow limitation by the Global Lungs Initiative equations in a cohort of very old adults.
    Turkeshi E; Vaes B; Andreeva E; Matheï C; Adriaensen W; Van Pottelbergh G; Degryse JM
    Eur Respir J; 2015 Jul; 46(1):123-32. PubMed ID: 25882799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the Slow Vital Capacity Clinically Useful to Uncover Airflow Limitation in Subjects With Preserved FEV
    Saint-Pierre M; Ladha J; Berton DC; Reimao G; Castelli G; Marillier M; Bernard AC; O'Donnell DE; Neder JA
    Chest; 2019 Sep; 156(3):497-506. PubMed ID: 30768928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.
    Montes de Oca M; Aguirre C; Lopez Varela MV; Laucho-Contreras ME; Casas A; Surmont F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3059-3067. PubMed ID: 27994446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1213-8. PubMed ID: 26150713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.